An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods (UChoose)

NCT02404038 NA UNKNOWN

This study will enrol sexually active, healthy girls aged 16-17 to assess and compare the acceptability and preference for a monthly vaginal ring, bi-monthly injectable contraception or daily dose oral contraception, as proxy for female-controlled ARV-based HIV prevention methods.

Details

Lead sponsor	Desmond Tutu HIV Centre
Phase	NA
Status	UNKNOWN
Enrolment	131
Start date	2015-07
Completion	2020-02-28

Conditions

• HIV

Interventions

• Nur-Isterate
• Nuvaring
• Triphasil

Primary outcomes

• 13-item Ortho Birth Control satisfaction assessment tool to measure acceptability of each contraceptive option — 32 weeks
  questionnaire administered after every 8 weeks on each contraceptive method

Countries

South Africa